Yong J. Lim

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The transplacental transfer of NHC, the active metabolite of molnupiravir, in the ex vivo human placental perfusion model.

The transplacental transfer of NHC, the active metabolite of molnupiravir, in the ex vivo human placental perfusion model.

Journal: Canadian journal of physiology and pharmacology

Published: July 30, 2026

The transplacental transfer of NHC, the active metabolite of molnupiravir, in the ex vivo human placental perfusion model.

The transplacental transfer of NHC, the active metabolite of molnupiravir, in the ex vivo human placental perfusion model.

Journal: Canadian journal of physiology and pharmacology

Published: July 30, 2026

Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients.

Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients.

Journal: British journal of clinical pharmacology

Published: January 22, 2026

Characterizing ex vivo models for studying lipid metabolism in triple negative breast cancer.

Characterizing ex vivo models for studying lipid metabolism in triple negative breast cancer.

Journal: Journal of lipid research

Published: January 12, 2026

DIATAGeR: Triacylglycerol annotation of data-independent acquisition based lipidomics.

DIATAGeR: Triacylglycerol annotation of data-independent acquisition based lipidomics.

Journal: Analytica chimica acta

Published: May 16, 2025

The impact of progressive chronic kidney disease on hepatic drug metabolism.

The impact of progressive chronic kidney disease on hepatic drug metabolism.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: October 10, 2024

Pharmacometabolomics in Drug Disposition, Toxicity, and Precision Medicine.

Pharmacometabolomics in Drug Disposition, Toxicity, and Precision Medicine.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: September 08, 2023

Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury.

Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 09, 2023

The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial.

The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: October 14, 2022

Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients.

Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients.

Journal: British journal of clinical pharmacology

Published: September 13, 2022

A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.

A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.

Journal: Canadian journal of kidney health and disease

Published: June 17, 2021

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.

Journal: Toxins

Published: December 22, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026